𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Pharmacokinetics and absolute bioavailability of salbutamol in healthy adult volunteers

✍ Scribed by D. A. Goldstein; Y. K. Tan; S. J. Soldin


Publisher
Springer
Year
1987
Tongue
English
Weight
301 KB
Volume
32
Category
Article
ISSN
0031-6970

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Intravenous pharmacokinetics and absolut
✍ Dan C. Dimmitt; Youn Sung Choo; Lorene A. Martin; Thangam Arumugham; William F. πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 766 KB

In this first part of a two-part investigation, the intravenous dose proportionality of dolasetron mesylate, a 5-HT 3 receptor antagonist, and the absolute bioavailability of oral dolasetron mesylate were investigated. In an open-label, randomized, four-way crossover design, 24 healthy men between t

Pharmacokinetics and relative bioavailab
✍ Iftekhar Mahmood; Jacqueline S. Marinac; Sandra Willsie; William D. Mason πŸ“‚ Article πŸ“… 1995 πŸ› John Wiley and Sons 🌐 English βš– 557 KB

## Abstract Selegiline is beneficial to Parkinsonian patients as an adjunct to levodopa therapy. A sensitive fluorimetric assay based on ibhibition of rat brain monoamine oxidase‐B (MAO‐B) __in vitro__ has been developed to study the pharmacokinetics of selegiline. This method quantitates selegilin

Single dose pharmacokinetics and bioavai
✍ Michael J. Lamson; John P. Sabo; Thomas R. Macgregor; Joseph W. Pav; Lois Rowlan πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 170 KB πŸ‘ 2 views

The results of two randomized, single-dose, crossover bioavailability studies are presented which describe the pharmacokinetics and oral bioavailability of nevirapine, a novel nonnucleoside antiretroviral drug. In the first study 12 healthy male volunteers received nevirapine 15 mg via short-term i.

PHARMACOKINETICS AND ABSOLUTE BIOAVAILAB
✍ Lisa Jo Benincosa; Patricia R. Audet; Dave Lundberg; NΓ©vine Zariffa; Diane K. Jo πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 509 KB

The objective of the current investigation was to describe the pharmacokinetics and absolute oral bioavailability of epristeride. Twelve healthy male subjects (mean (SD) age, 27 (6.2) years) received a single oral dose of 5mg and an intravenous infusion of 4.5 mg over 30 min in a crossover fashion.